|Articles|January 21, 2020
CureDuchenne Joins Vivli
Advertisement
CureDuchenne has announced that they will contribute patient-level clinical data for treating muscular dystrophy to the Vivli platform. The data will supplement existing studies that are available to request on the Vivli platform and be available to other researchers around the world.
For more information, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Reasoning About Individual Drug Causality in a Multifactorial World
2
Why Trial Competition Is Undermining AI-Driven Gains
3
BostonGene Expands AI-Driven Oncology Collaborations with New AstraZeneca Deal
4
ACT Brief: Recalibrating Trial Efficiency and Access, Verana-COTA Merge to Expand RWE Scale, and FDA Rejects Hetlioz Jet Lag Indication
5